Associations between residential exposure to volatile organic compounds (VOCs) and liver injury markers ======================================================================================================= * Banrida Wahlang * Tyler C. Gripshover * Hong Gao * Tatiana Krivokhizhina * Rachel J. Keith * Israel D. Sithu * Shesh N. Rai * Aruni Bhatnagar * Craig J. McClain * Sanjay Srivastava * Mathew C. Cave ## ABSTRACT Occupational exposures to volatile organic compounds (VOCs) have been associated with numerous health complications including steatohepatitis and liver cancer. However, the potential impact of environmental/residential VOC exposures on liver health and function is largely unknown. To address this knowledge gap, the objective of this cross-sectional study is to investigate associations between VOCs and liver injury biomarkers in community residents. Subjects were recruited from six Louisville neighborhoods, and informed consent was obtained. Exposure biomarkers included 16 creatinine-adjusted urinary metabolites corresponding to 12 parent VOCs. Serological disease biomarkers measured included cytokertain-18 (K18 M65 and M30), liver enzymes and direct bilirubin. Associations between exposure and disease biomarkers were assessed using generalized linear models. Smoking status was confirmed through urinary cotinine levels. The population comprised of approximately 60% females and 40% males; White persons accounted 78% of the population; with more nonsmokers (n=413) than smokers (n=250). When compared to nonsmokers, Males (45%) and Black persons (26%) were more likely to be smokers. In the overall population, metabolites of acrolein, acrylonitrile, acrylamide, 1,3-butadiene, crotonaldehyde, styrene and xylene were positively associated with alkaline phosphatase (ALP). These associations persisted in smokers, with the exception of crotonaldehyde, and addition of N,N dimethylformamide and propylene oxide metabolites. Although no positive associations were observed for K18 M30, the benzene metabolite was positively associated with bilirubin, irrespective of smoking status. Taken together, the results demonstrated that selected VOCs were positively associated with liver injury biomarkers. These findings will enable better risk assessment and identification of populations vulnerable to liver disease. Key words * VOCs * liver injury * smoking * residential * ALP ## INTRODUCTION Volatile organic compounds (VOCs) are environmental chemicals that are anthropogenic or naturally-occurring; these chemicals have a high vapor pressure and low water solubility, and therefore, are often emitted as gases in indoor and outdoor air. While most of these volatile chemicals, such as trichlorethylene, toluene and benzene, are typically used as solvents in a wide range of industrial and chemical applications; other VOCs including acrylamide and styrene have been used in rubber and plastic manufacturing (Cruz and Bowen, 2021). Their applications in a variety of industrial products, such as petroleum fuels and hydraulic liquids, also make them common ground-water contaminants. Importantly, VOCs are also emitted from numerous business and household products (Lim et al., 2014), as well as from cigarette/tobacco smoke (Nazaroff and Singer, 2004; Sheu et al., 2020), resulting in different kinds of exposures extending from occupational or industrial to residential or environmental. Occupational exposures to VOCs have been shown to cause adverse health effects, ranging from different forms of cancers such as lung, liver, and kidney cancers, to neurotoxicity and neuro-behavioral deficits, depending on the type(s) of VOC (Cave et al., 2010; Cruz and Bowen, 2021; Lamplugh et al., 2019; Walker et al., 2016; Warden et al., 2018). These occupational exposures oftentimes occur at higher doses and can be acute (short-term exposures) or chronic (longer-term exposures). In contrast, residential VOC exposures often occur at lower doses over an extended period of time, usually when people inhale VOCs residing within their environment, which frequently are VOCs found in household or indoor air (Vardoulakis et al., 2020). Although occupational VOC exposures have been associated with cardiovascular diseases and liver injury (Cave et al., 2011; Cave, et al., 2010; Gresner et al., 2021; Ma et al., 2010), less is known about the impact of residential VOC exposures on cardio-metabolic diseases including liver injury and non-alcoholic fatty liver disease (NAFLD). The liver is the principal organ for chemical detoxication, which also makes it a general target organ for many environmental chemicals. Indeed, previous epidemiologic and rodent studies have demonstrated the toxicological effects of VOCs on liver health and function (Lang and Beier, 2018; Wahlang et al., 2019). Clinically, liver injury has traditionally been assessed by circulating liver enzyme levels such as plasma alanine and aspartate transaminases (ALT, AST), and alkaline phosphatase (ALP). More recently, our group and others have used plasma cytokeratin 18 (K18) M65 and M30 as alternative non-invasive biomarkers for liver injury, in relation to environmental chemical exposures (Cave, et al., 2011; Clair et al., 2018; Werder et al., 2020). Aside from elevated K18 levels, exposures to industrial VOCs, such as vinyl chloride and styrene, have been associated with toxicant-associated steatohepatitis (TASH) in rubber plant workers, with mechanistic toxicity including necrosis (Cave, et al., 2011; Cave, et al., 2010). TASH is a form of non-alcoholic steatohepatitis (NASH), and share similar pathologies and molecular disease development events as NASH (Wahlang et al., 2013). Both TASH and NASH fall under the bigger description of liver pathology, namely, NAFLD, which consist of a spectrum of hepatic disorders, initially manifested by fat accumulation in the liver (steatosis), and this could be accompanied by inflammation (steatohepatitis). If untreated, steatohepatitis could progress to fibrosis and cirrhosis and fulminant liver failure. Notably, the prevalence of TASH has also been observed in populations exposed to other classes of pollutants such as persistent organic pollutants (Clair, et al., 2018; Wahlang, et al., 2013; Wahlang, et al., 2019), and therefore it is important to assess the effects of residential VOCs on such liver endpoints. Health consequences resulting from exposures to environmental pollutants are heavily dictated by non-pollutant factors such as proximity to a polluted site, socio-economic factors, race, sex and lifestyle choices including smoking, high caloric intake and physical activity. These factors influence levels of both exposure and disease biomarkers, as well as health outcomes associated with exposures; for instance smokers may have higher VOC exposure levels originating from cigarette smoke (Nazaroff and Singer, 2004). Most environmental epidemiologic studies have begun taken into consideration the role of such factors when investigating associations and correlations between environmental chemical exposure and disease. In concordance with such studies, the objective of the current study is to investigate associations between residential exposures to VOCs using urinary VOC metabolites, and liver disease biomarkers, to better understand hepatic mechanisms related to chronic, low dose VOC inhalation. In addition, the study utilizes a stratified approach to better assess differences in associations between smokers *vs.* non-smokers, as well as how sex and race may influence the observed associations. ## MATERIALS AND METHOD ### Recruitment and Study Population The current study which is part of the Health, Environment and Action in Louisville (HEAL) study, was approved by the University of Louisville Institutional Review Board. A total of 735 consenting study subjects were enrolled by the University of Louisville, from six neighborhoods in South Louisville, Kentucky, between May 2018 and September 2019. All subjects were between 25 to 70 years of age. Individuals unwilling or unable to provide written informed consent were excluded. Individuals with significant and/or severe comorbidities were also excluded. These comorbidities included HIV/AIDS, active treatment for cancer, and active bleeding including wounds. Other excluded subjects were pregnant women, prisoners, or other vulnerable populations. Blood and urine specimens were collected from the enrolled subjects. Demographic information including age, sex, race, smoking and drinking history, medical information including diabetes, cardiovascular diseases, and other chronic conditions were obtained through the questionnaires. BMI was calculated from the self-reported height and weight. Demographic characteristics of the study population are provided in **Table 1**. View this table: [Table 1.](http://medrxiv.org/content/early/2021/08/29/2021.08.25.21262640/T1) Table 1. Characteristics of the study population by nonsmokers and smokers. Of those enrolled in the current study, 46 subjects did not provide blood specimens, 2 subjects did not have liver enzymes/bilirubin measurements, 10 subjects did not provide urine specimens, 11 subjects were missing covariates such as BMI or drinking information, and 2 subjects had severe obesity. One subject with an extreme value of serum cytokeratin 18 (K18) M30/M65 ratio was also excluded from the analysis. Smoking status was confirmed using normalized urinary cotinine levels, with a value of >40 µg/g creatinine indicating current smoking status. The final study population consisted of 663 subjects (**Figure 1**) ![Figure 1.](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2021/08/29/2021.08.25.21262640/F1.medium.gif) [Figure 1.](http://medrxiv.org/content/early/2021/08/29/2021.08.25.21262640/F1) Figure 1. A flowchart depicting the final study population after applying exclusion criteria. ### Quantification of Urinary VOC Metabolites A panel of 16 VOC metabolites from 12 parent compounds, and the nicotine metabolite (cotinine) in spot urine samples, were quantified using a modified version of ultra-performance liquid chromatography-mass spectrometry (UPLC-MS/MS) method (Alwis et al., 2012; Lorkiewicz et al., 2019). All analytes were normalized to urinary creatinine levels to adjust for dilution. A list of all 16 VOC metabolites and their abbreviations, the corresponding parent compounds, and the percent lower than the limit of detection (% < LOD) is provided in **Table 2**. View this table: [Table 2.](http://medrxiv.org/content/early/2021/08/29/2021.08.25.21262640/T2) Table 2. A list of the 16 volatile organic compounds (VOC) metabolites measured in the total study cohort, their parent compounds, and the percent lower than the limit of detection (%